Gloghini Annunziata, Volpi Chiara C, Gualeni Ambra V, Dolcetti Riccardo, Bongarzone Italia, De Paoli Paolo, Carbone Antonino
a Molecular Pathology, Department of Diagnostic Pathology and Laboratory Medicine , Fondazione IRCCS Istituto Nazionale dei Tumori , Milano , Italy.
b University of Queensland Diamantina Institute, Translational Research Institute , University of Queensland , Brisbane , Australia.
Expert Rev Hematol. 2017 Jun;10(6):505-514. doi: 10.1080/17474086.2017.1326815. Epub 2017 May 16.
Primary effusion lymphoma (PEL) is a rare B-cell lymphoid neoplasm mainly associated with HIV infection, presenting as pleural, peritoneal, and pericardial effusions. A defining property of PEL is its consistent association with Kaposi sarcoma associated herpesvirus (KSHV) infection, and, in most cases, Epstein Barr virus (EBV) co-infection. On these grounds, a review of the literature related to viral cooperation and lymphomagenesis can help to understand the complex interplay between KSHV and EBV in PEL pathogenesis. Areas covered: In this review, the authors highlight clinical, pathologic, genetic and proteomic features of PEL, in the context of viral cooperation in PEL lymphomagenesis. Expert commentary: Tumour cells are characterized by the overexpression of genes that are involved in inflammation and invasion. Coherently, PEL secretomes are enriched in proteins probably responsible for the particular tropism (cell adhesion and migration) of PEL cells. The development of PEL in HIV+ patients is multifactorial and involves a complex interplay among co-infection with oncogenic viruses (EBV and KSHV), inflammatory factors, and environmental conditions.
原发性渗出性淋巴瘤(PEL)是一种罕见的B细胞淋巴瘤,主要与HIV感染相关,表现为胸腔、腹腔和心包积液。PEL的一个决定性特征是其与卡波西肉瘤相关疱疹病毒(KSHV)感染始终相关,并且在大多数情况下与爱泼斯坦-巴尔病毒(EBV)共同感染。基于这些原因,回顾与病毒协同作用和淋巴瘤发生相关的文献有助于理解KSHV和EBV在PEL发病机制中的复杂相互作用。涵盖领域:在本综述中,作者在PEL淋巴瘤发生过程中病毒协同作用的背景下,强调了PEL的临床、病理、遗传和蛋白质组学特征。专家评论:肿瘤细胞的特征是参与炎症和侵袭的基因过度表达。相应地,PEL分泌组富含可能负责PEL细胞特殊趋向性(细胞黏附和迁移)的蛋白质。HIV阳性患者中PEL的发生是多因素的,涉及致癌病毒(EBV和KSHV)共同感染、炎症因子和环境条件之间的复杂相互作用。